Cargando…
Uses of equipoise in discussions of the ethics of randomized controlled trials of COVID-19 therapies
BACKGROUND: Early in the COVID-19 pandemic, the urgent need to discover effective therapies for COVID-19 prompted questions about the ethical problem of randomization along with its widely accepted solution: equipoise. In this scoping review, uses of equipoise in discussions of randomized controlled...
Autores principales: | Nix, Hayden P., Weijer, Charles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8528943/ https://www.ncbi.nlm.nih.gov/pubmed/34674679 http://dx.doi.org/10.1186/s12910-021-00712-5 |
Ejemplares similares
-
Equipoise, design bias, and randomized controlled trials: the elusive ethics of new drug development
por: Fries, James F, et al.
Publicado: (2004) -
Does clinical equipoise apply to cluster randomized trials in health research?
por: Binik, Ariella, et al.
Publicado: (2011) -
Ethics of randomised controlled trials – not yet time to give up on equipoise
por: Ashcroft, Richard E
Publicado: (2004) -
Equipoise, design bias and randomized controlled trials: the elusive ethics of new drugs – a comment
por: Schimetta, Wolfgang, et al.
Publicado: (2005) -
Ethical considerations within pragmatic randomized controlled trials in dementia: Results from a literature survey
por: Nicholls, Stuart G., et al.
Publicado: (2022)